# OnCo record velosbio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/velosbio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "velosbio" ;
  schema:name "VelosBio"@en ;
  schema:alternateName "VelosBio Inc."@en ;
  schema:description "VelosBio was a privately held company that developed VLS-101, now zilovertamab vedotin, an antibody that carries a drug to cancer cells carrying a protein called ROR1. Merck bought it in 2020."@en ;
  schema:url <https://onco.cc/companies/velosbio/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.merck.com/news/merck-to-acquire-velosbio/>, <https://www.sec.gov/Archives/edgar/data/310158/000031015821000004/mrk-20201231.htm> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/> ;
  onco:targets <https://onco.cc/targets/ror1/> ;
  onco:drugs <https://onco.cc/drugs/zilovertamab-vedotin/> .